• Clip News: Display Concepts - Clip Distributor Completes a Stunning Exhibition Stand Design  Read More...
  • Clip News: Clip Stand confirmed at Institute of Fundraising November 23rd & 24th, a must for all Charity contacts, come & see us on stand number two!
  • Clip News: Just finalised a stand at World Travel Market for a long standing Clip user!
  • Clip News: The team at Clip are developing,maufacturing and installing a new contemporary brand awareness and hospitality area at its world leading leisure industry clients UK Headquarters
  • Customer comments: Great to hear this from one of our customers "I have not forgotten how useful Clip and your good self were whilst I was at Tensar/Carborundum”.  Our hardworking team did themselves credit...
  • Clip News: Finalised site plans for Shanghai Motor Show, penultimate leg of Saint-Gobains global event programme for 2011, great first year working with this new partner’
  • Clip News: Discussing brief for 12m x 10m stand with Clip in-house design dept for DUK March 2012
  • Clip News: Finalised plans for small stand and external branding at British Free Range Egg Producers Association Conf November 2011
  • Have you seen our online shop for exhibition supplies? View it here...
  • Clip News: Supporting a long standing client again at the Inter Airport Show in Munich by building a 60 square metre stand

Exhibition Stands News

Product licence for Prostrap moves from Wyeth to Takeda

23 Mar 2009

The product licence for a LH-RH agonist used to treat prostate cancer, endometriosis and uterine fibroids is to revert back to Takeda from Wyeth.

Marketing authorisation for the Prostrap (leuprorelin acetate) range in the UK and Republic of Ireland has been held by Wyeth since 1990, but from July 1st this year it will be controlled by Takeda.

The company''s managing director for UK operations Trevor Smith said this addition will enrich its portfolio and help to develop its emerging franchise in the oncology field.

Other products currently marketed by the group include Bronica (seratrodast) and Solfa (amlexanox), which are used for the treatment of bronchial asthma and allergic rhinitis respectively.

Takeda is headquartered in Osaka, Japan, but has subsidiaries and affiliates across the globe, in locations such as the UK, Italy, Ireland, China, Singapore and Austria.

Its net sales for the year ending March 2008 totalled 1,375 billion yen (£9.76 billion).ADNFCR-2086-ID-19088010-ADNFCR